• 4356 Citations
  • 35 h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 28 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Biliary Tract Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

Shroff, R. T., Kennedy, E. B., Bachini, M., Bekaii-Saab, T., Crane, C., Edeline, J., El-Khoueiry, A., Feng, M., Katz, M. H. G., Primrose, J., Soares, H. P., Valle, J. & Maithel, S. K., Apr 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 12, p. 1015-1027 13 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Practice Guidelines
Gallbladder Neoplasms
Cholangiocarcinoma
Randomized Controlled Trials

CanStem111P trial: A Phase III study of napabucasin plus nab-paclitaxel with gemcitabine

Sonbol, M. B., Ahn, D., Goldstein, D., Okusaka, T., Tabernero, J., Macarulla, T., Reni, M., Li, C. P., O'Neil, B., Van Cutsem, E. & Bekaii-Saab, T., Apr 1 2019, In : Future Oncology. 15, 12, p. 1295-1302 8 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Adenocarcinoma
Clinical Trials
Safety
1 Citation (Scopus)

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial

Shroff, R. T., Javle, M. M., Xiao, L., Kaseb, A. O., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., Ahn, D., Bekaii-Saab, T. & Borad, M. J., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

gemcitabine
Biliary Tract Neoplasms
Nanoparticles
Cisplatin
Clinical Trials

Impact of tumor location and variables associated with overall survival in patients with colorectal cancer: A mayo clinic colon and rectal cancer registry study

Wang, C. B., Shahjehan, F., Merchea, A., Li, Z., Bekaii-Saab, T., Grothey, A. F., Colibaseanu, D. T. & Kasi, P. M., Jan 1 2019, In : Frontiers in Oncology. 9, FEB, 76.

Research output: Contribution to journalArticle

Open Access
Rectal Neoplasms
Colonic Neoplasms
Registries
Colorectal Neoplasms
Survival
2 Citations (Scopus)

Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors

Hong, D. S., LoRusso, P., Hamid, O., Janku, F., Kittaneh, M., Catenacci, D. V. T., Chan, E., Bekaii-Saab, T., Gadgeel, S. M., Loberg, R. D., Amore, B. M., Hwang, Y. C., Tang, R., Ngarmchamnanrith, G. & Kwak, E. L., Apr 15 2019, In : Clinical Cancer Research. 25, 8, p. 2403-2413 11 p.

Research output: Contribution to journalArticle

Maximum Tolerated Dose
Neoplasms
Headache
AMG-337
Nausea